The global rotavirus vaccines market size was valued at USD 5.19 billion in 2024 and is projected to grow from USD 5.22 billion in 2025 to USD 10.21 billion by 2032, exhibiting a CAGR of 10.1% during the forecast period. North America dominated the rotavirus vaccines market with a 38.53% share in 2024, supported by strong immunization programs, rising awareness of pediatric infectious diseases, and robust healthcare infrastructure.